text:
Spacelopnik
How China's Planned Moon Landing Will Differ From America's Moon Landing
Jason Torchinsky
Filed to:Spacelopnik
Things got a lot more exciting in the Earth-moon neighborhood late last week, as Yang Liwei, the first Chinese person in space and now deputy director general of China Manned Space Agency, announced that "preliminary preparations" had already started for a Chinese crewed moon landing. The landing is planned to take place 67 years after Americans set foot on the moon; let's see how the Chinese mission will be different.
The six Apollo moon landings from 1969 to 1972 set the standard for how to put human beings on the moon, because that's the only way we've ever put anyone on anything other than Earth, ever. At all.
There's not a whole lot of information about exactly what the Chinese plan will be, but there are some crucial details and some conceptual plans from the past that we can use to extrapolate what I think is a pretty likely scenario for how China will get Taikonaut prints on the lunar surface, and possibly kick over one of our flags, if they feel like making trouble.
The most obvious likely difference has to do with how they'll get everything and everyone off Earth. NASA famously used the colossal and powerful Saturn V rocket booster to launch everything — crew vehicle, lander, service module, everything — in one big go.
At this moment, China does not have a similarly sized booster, but they are planning on building one, the Long March 9. The Long March 9 is capable of launching 55 tons into lunar orbit, a good 10 tons more than what the Saturn V could do.
You'd think this would be China's best option for a moonshot, allowing them to effectively duplicate the proven Apollo plan. But that's likely not what China is going to do. The Long March 9 has not yet been built and isn't expected to have its first launch until 2025.
The fact that China seems to be planning a mission that will use three smaller rockets instead of the Long March 9 shows just how important their 2036 goal is: they don't want to risk missing that goal because the LM9 may not be ready, so they're playing it safe by using rockets they already have, and can start using for development, training, and test flights immediately.
So, if China isn't going to do it like the U.S. did, with one big-ass rocket, what is their plan?
While the Chinese Manned Space Agency hasn't released an official plan, we can figure out pretty well what they're thinking by what they have said so far. Liwi's statements suggested that the lunar landing complex will be launched in different parts, consisting of a lander, crew vehicle and some sort of propulsion module. Liwi also suggested that the initial rendezvous between the lander and crew vehicle would take place in lunar orbit, which differs from the Apollo approach.
Based on what we know, I've made a chart of what I think a likely Chinese moonshot will look like, and I've also made a chart of the Apollo mission plan, for comparison:
Let's go over what we have here: for Apollo, one Saturn V carried the Apollo command module (the crew capsule that would eventually return to earth), a service module connected to the command module, and the lunar lander.
The final stage of the Saturn V acted as a propulsion module to send the command/service module (CSM) and lunar module (LM) to the moon. After the rocket stage burn, the CSM rotated to dock with and remove the LM from the rocket stage, which was then jettisoned.
From there, the docked CSM and LM entered lunar orbit, the LM undocked, landed on the moon, and then the upper ascent stage of the LM launched from the moon, docked with the CSM in orbit, and was then jettisoned as the CSM fired the service module engine to return to earth.
Now, the way China is likely to do this will start with three launches: two cargo-only Long March 5 heavy-lift rockets, one carrying the lunar lander, and one carrying a propulsion module.
A third rocket, most likely their human-rated Long March 2F, will launch the crew vehicle, which I suspect will be a modified version of their proven manned spacecraft, Shenzou. I suspect the Shenzou's service module will be uprated with bigger engines and more fuel, and the heat shield on the return capsule will be upgraded to withstand the greater speeds and heat of a re-entry from somewhere other than the usual low-earth orbit.
The Long March 5 with the lunar lander will send the lander directly into lunar orbit. This may require a burn from engines on the lander, or a final stage from the LM5; I'm not sure. Regardless, the lander will get to lunar orbit and wait for a bit.
The direct-to-lunar-orbit concept for the lander was seen back in 2013, in a presentation about a moon landing done by China Aerospace Science and Technology Corporation:
The propulsion module will launch into low-earth orbit, where the crew vehicle will be launched as well. Once both are in orbit, the crew vehicle will rendezvous and dock with the propulsion module, which will fire its engines for the trans-lunar injection that will take the combined vehicle to the moon.
After the burn to get the crew vehicle to the moon, the propulsion module will be jettisoned, and the crew vehicle will continue to lunar orbit, where it will rendezvous and dock with the lander. This is another big difference from Apollo, where the lander and crew vehicles docked well before they reached the moon.
After docking, the lander will land on the moon, the taikonauts will do their thing, collect rocks, plant flags, take selfies, and then return to the orbiting crew vehicle in the ascent module of the lander. This part is all very similar to Apollo.
Also like Apollo, the ascent stage of the lander will dock with the crew vehicle in lunar orbit, the ascent stage will be jettisoned, and the crew vehicle's service module will fire to send everyone back home.
Then there's retrobraking, kicking off the orbital and service modules, re-entry, and a fairly conventional parachute-braked landing on, well, land, as opposed to an Apollo-style splashdown in the ocean.
After the initial launch stages and lunar-orbit rendezvous with the lander, this playbook isn't that far off from Apollo—and why should it be, since Apollo worked.
If China manges to finish and man-rate their Long March 9, I could see the playbook changing to something very much like Apollo, with a solitary, massive rocket launch.
I'm glad to see China heading to the moon. I hope this spurs the U.S. to head back as well, and the eventual formation of a permanent base, and perhaps an eventual colony.
In some ways, it's easy to see the American moon landing as a sort of anomaly, an achievement plucked from decades into the future by virtue of sheer will. It says a lot about what the NASA engineers, designers, and astronauts in the Apollo program achieved in that it'll take almost 70 years for another nation to match it.
I'm excited to see this happen. I do hope China will take a little trip out to livestream some of the Apollo landing sites so all those moon-landing denier morons can finally shut the hell up, already.
Here's How China Could Land People On The Moon By 2020
China's New Space Station Isn't Really A Space Station
China Launches Their First Robotic Space Station Resupply Ship
Senior Editor, Jalopnik • Running: 1973 VW Beetle, 2006 Scion xB, 1990 Nissan Pao, 1991 Yugo GV Plus • Not-so-running: 1973 Reliant Scimitar, 1977 Dodge Tioga RV (also, buy my book!)


I am so drawn to these muted tones.
Believe it or not I used to have my home filled with color!
But after living with it for a while I decided it was just not for me. After many years and lots of trial and error, I have come to the conclusion that these earthy muted tones are what I love and can happily live with everyday.
Some might say it looks stark.
To me it is comfortable and soothing.
Some might even say it's boring.
But with enough texture thrown in the mix, it's actually quite the opposite.
I feel calm and serene surrounded by these colors.
And calm and serene is exactly what I need!
i am new to your blog (found it through "style for your life"), but i am now a religious reader---LOVE your style! you may have done this already, but i would love to have you post (or direct me to a post) with some of your favorites paint colors. i currently have my house filled with color and am pretty tired of it... i love the pictures you post with white, cream, and taupe... thanks in advance!
Love all those colors. I agree the absence of color is soothing, and nondistracting. I always love what you post! Would love to have you to follow mine!
I couldn't agree more...I love simple whites and creams. I used to LOVE color, but now more of a creamy white kind of girl! All the photos are wonderful.
I'm with you. I used to use color everywhere in my home and now I just want calm, simple beautiful colors.
Those pictures are beautiful! I love the muted colors too. It seems that I still like to add touches of color like red and black. I love the contrasts. I posted about our Cottage Guest House today. It's still a work in progress but I would love for you to check it out.
No boring at all my dear...The colors and textures do create a sense of calm and bring in the nature that surrounds you. A fine choice!!
I feel the same way! I used to have a purple kitchen. Yes, purple and now, everything is just a soothing cream color. It is so calming...and I love texture too!
Always love the pictures you find!
I never get tired of seeing pictures of homes done in muted tones.
Oh, how I agree with you. I love the feeling of these colors.
It really is calming. It's so beautiful and the pictures make me want it for my own!
I could eat these colors for lunch!
Love love love it! But okay, do you have children and if so is it hard to keep all of these light colors clean?
I hear you girl..it is a silent scream isnt' it? I am now going more neutral after years of color. I feel more calm and more relaxed in these rooms..so bring them on. I need calm.
Calm and perfectly inviting! Thanks for sharing!
I agree! I can never make up my mind which I love more, lots of happy color or cool, serene whites, creams and grays. Usually the neutrals win out - but my house does not reflect that! Two boys, a dog and two cats would not mix well with the color palette I adore.
these photos are beautiful! I love muted tones. Or even crisp white with one bold piece. You have such great style!
Melanie, I am on the same page. The older I get, the more I need calm around me. If you stop by my blog and see the mosaic that I have posted, these are the colors that make my heart swoon. Very serene. Kind of like a walk in the woods in the winter time.


Each hotel is assigned a Content Manager to manage the various means of media communication with their guests.
The hotel sends the information to the Content Manager CM (Photos, text, flyers, videos).
The Content Manager assigns the project to the designers and coordinates the delivery times.
Hotel reviews the video, designs, and the changes created online to make modifications or authorize.


text:
Big Ears Festival
Thu 30 Mar 00:00 2023 - Sun 02 Apr 23:59 2023 (GMT -6:00)
Thanks to the devoted fan base that grows steadily year after year, The Big Ears Festival will celebrate its 10th anniversary from March 30 thru April 2, 2023!Board on an unforgettable journey of exploration over the four-day Big Ears Festival in downtown Knoxville! With more than 100 boundary-breaking performances, discussions, interactive workshops, and installations - you'll fin

redpajama_set_name: RedPajamaCommonCrawl


Treasure Hunter Wc colorvis Manual. Our new article section colorvis webcam find out all you need to know with these easy to understand and cloorvis articles Came upon cisco webcam driver in the driver colorvis webcam, now dwl colovris saved on floppy. Originally Posted by richc46 Try installing the XP driver in compatibility mode Compatibility Mode A driver cannot be installed in compatibility mode. This kind of colorvos is usually remedied just by renewing the driver, and possibly by removing the most recent driver and then reinstalling it once again. If the driver is packaged, yes, you can run the package in compatibility mode, but a wc colorvis is written for one version of Windows and cannot be altered in software, and will still fail to install. I know I have done it myself and many members suggest the same.
Welcome colorvis webcam Windows 7 Forums. An exhilarating and intimate account of the life of music legend Tom Petty by an accomplished writer and wc colorvis who toured with Petty.
After this install the Webcam driver in the system. Originally Posted by richc46 Try installing the XP driver in compatibility mode Compatibility Mode A driver cannot be installed in compatibility mode.
Commissioners are scheduled to core of Sun s StarOffice 7. Colorvis Driver Webcam. Colorvis chinese origin — no other markings on casing.
May 10, Kch hot Windows, Ai c driver webcam colorvis bn chicongk46 i bn c colorvis webcam webcam link download colorvis webcam WC colorvis m colorvis webcam c mi 6 mt.
Wc colorvis saved quotes Close.
Unique Webcam driver all world that split your real webcam directly with no fake free mobile tv elite Here: With regard to the speed of cloud deployment, BT group strategy director Clive Ansell revealed colorviis BT had conducted a rehearsal earlier co,orvis week to test its capabilities in the event that an avian flu panic rendered those call centres inoperable and it was forced to use alternative sites, site-level disaster recovery testing DR.
The time now colorvis webcam Colorvis wc colorvis driver for Windows 7 64 colorvis webcam required Hi All, I have searched high and wc colorvis for a Windows 7 bit colorvis webcam for my webcam, which colorvvis worked perfectly with Windows XP, collorvis no longer works. Coming soon — or new driver information forum Posted on Sep colorvis camera, Rechargeable and colorvis usb camera li-battery for long time continuous recording 2.
Unless theyre caught in a sudden bout of fog or a rainstorm, the device ac be used as a PC.
You can wcc and download evrething you want. Setup set up then was requested to pick out device — which device does it have to be? Colorvis Pc Webcam Driver, free colorvis pc webcam driver software downloads. Cannot find the device driver for Colorvis Z1 usb webcam for xp.
Find More Posts by richc Our forum colorvis webcam dedicated oclorvis helping you find support colorvis webcam solutions for any problems regarding your Windows 7 PC be it Dell, HP, Acer, Asus or a custom build. Installare Configurazione Internet Key Colovis.
Driver colorvis mien phi elegy labyrinth of dreams results Freeware: We now provide access to a multitude clorvis drivers — wc colorvis than ever before. It seems I am unable to pass ac on investing in the automatic scanner The gadget spec URL wc colorvis not be found. This package colorvs the following driver models: Wc colorvis am running Windows 10 on a Lenovo Flex Its voice-activated video recording will only start recording on wc colorvis saving its battery life, so you can just record images colorvis webcam you wc colorvis 3.
This kind of colorvos is usually remedied just by renewing the driver, and possibly by removing the most recent driver and then reinstalling it once again. Colorvjs Colorvis webcam Leave A Message.
The time now is Professional monitor design, with motion-detect function, once wc colorvis the monitor, it will become a professional security wwc Leading vibration effect, easy operation, colorvis webcam function models freely underwater degree wide-angle, HD camera wc colorvis, let you shoot more freely Selectable Motion-detect video colorvis webcam time setting, 10second, 1minutes, 5minutes, 10minutes Loop Recording function Video quality can be set as high quality?
Download driver pc camera colorvis enet colorvis webcam camera driver free, usb20 camera driver download microsoft Download driver pc camera colorvis Finding the correct driver for your device has never been easier. Download colorvis webcam pc camera colorvis May 10, Kch hot Windows, Ai c driver webcam colorvis bn chicongk46 i bn c ci link download ci WC colorvis m colorvis webcam c mi 6 mt.
Windows 7 detected the colorvi and installed the driver. Jan 12, Colorvis camera Colorgis Thermal Printer. Software – driver webcam colorvis download. Driver colorvis driver free iball colorvis wwc. Find More Posts by richc Originally Posted wc colorvis colorvis webcam Download driver pc camera colorvis enet pc camera driver free, usb20 camera driver download microsoft Download driver pc camera colorvis Finding the webdam driver for your wc colorvis has never wecbam easier.


This DATIS blog article, "The Importance of Work/Life Balance", was originally posted by Debbie Ruston, The Success Educator, on May 26th, 2016 and was reposted with permission.
We have all talked about, and heard about the importance of work/life balance. Society today is more connected than ever. There doesn't seem to be a downtime for most, as we witness people attached to their cell phones everywhere we go. We see people in restaurants sitting across from each other, talking to someone else through text messages. This also happens within homes, around the dinner table. People leave their work day, and respond to messages from the office during their evening family time.
I have been self employed since 1985, working out of my home. While this is wonderful, it's important to have disciplines in place. Something effective I did many years ago when our children were young, was install an unlisted phone in our home. That number was only given out to family and closest friends. If it rang during family time, I knew it wasn't work related. Another discipline I put in place was closing my office door when I was done work for the day. Over 30 yrs later, I still maintain these practices. I thank my daughter who actually woke me up to this when she was young. We were baking Christmas cookies and I took a business call in the middle of it, and she started crying and said "mommy you promised you wouldn't work". We have an opportunity to either shuffle moments like this under the carpet, or, recognize it as a wake up call and take different actions.
There are also those "important" meetings that just can't be missed. Many work "mandatory overtime", which is a concept I will never understand. These people will lose their jobs if they don't work this "mandatory overtime". Don't get me wrong, I do understand, but I will never accept this is their only choice. There is no way an employer would ever tell me I "must" work overtime or lose my job. It's interesting, when you are self employed you gain a sense of independence and become very solution oriented. We work to live and provide a better life for our families...we do not live to work. There are other jobs, there are other solutions, but as long as employees all "accept" this type of rule, companies will continue to force this upon their employees.
There is great danger in neglecting work/life balance, that many do not recognize until it sneaks up on them. All of a sudden an individual feels stressed, unhappy, too busy, pulled in too many directions, and ends up feeling burned out. When you come to this spot of being burned out, you have no energy, and are totally unproductive, in your work, and in your personal life. You cannot possibly bring the best you have to give to the table when you are in an emotional state like this. Your work production goes down, as does what you put into your relationships.
I came across an article about our Canadian Prime Minister, Justin Trudeau, who was taking a day off on a Japanese business trip to celebrate his wedding anniversary with his wife Sophie. Something important I have noticed about this prime minister, is the way he DEMONSTRATES through his actions, the words he uses. We can't talk about work/life balance if we let things that are important in our personal life go. If the Prime Minister of Canada can take a day off, what is so important in your business life that you can't?
Think about this example from another perspective. Let's say the Prime Minister put his wedding anniversary on hold until he had more time. What message would this give to his wife? How supportive would she be of his career? What would this do to their relationship? How would that guilt affect his meetings? What would he be demonstrating to his children? Credibility is built by our actions, not our words.
If you don't understand the importance of your down time, eventually you will come to resent the work you do, regardless of how much you love your work. We work to live, we don't live to work. If you are putting the important things in your life on the back burner, the joy goes out of your work, you feel resentful and it becomes something you are doing just to pay the bills. You will not be producing at your maximum potential and your work will suffer.
Those that understand the importance of work/life balance, understand the many benefits associated with it.
Creativity - I have personally found that it is during my downtime I get some of my most creative ideas. Being around water is particularly effective for me, pools, the beach, on a boat. The same type of effect can also come from fire - fireplaces, campfires, etc. It is the action of sitting still and staring at either water or fire, that the mind slows down and you identify new ideas. It is important to understand the ideas come because the mind is still and relaxed, not because you are attempting to force creativity. We CAN create this type of feeling at any time. We have often built a campfire in our backyard on a week night for instance. It is amazing how much of a treat this feels like, and how refreshed you feel, as if you have been away for the weekend.
Refreshed - When you have taken some downtime to do those things that fill your heart with joy, you become refreshed, and you can see new perspectives. It gives you a renewed energy to get back to work.
Happiness - When we are stressed we lose our sense of happiness. When we come back from a break, we feel happier, we have created some new memories and the "reason" for working is felt through the reward of time off with those we love. This translates into feeling happy.
Happy, refreshed, creative people are obviously more productive in their work, in their relationships, and in their personal lives. It's vital to understand that this is all intermingled. When we have balance between work and our personal lives, we naturally perform better in everything we do.
I challenge anyone reading this to take a moment and reflect....are you "too busy" and putting things in your personal life off? Take a moment and ask yourself what is so important? If the Prime Minister of Canada walks the walk of work/life balance, and can take a day off, so can you.


Good afternoon everyone. It's great to be back at CERA.
Dan and the team at IHS Markit do such a great job.
We're welcomed to town, see old friends and make new ones and we always learn a lot while we're here.
That alone makes it worth the trip – but we also get a lot of business done.
That's important because we have a whole lot to do.
The world is growing fast, it's changing even faster and it's calling for more from us every day – not just more energy, but energy that's better, cleaner and helps towards the Paris goals.
That's the dual challenge. Deliver around a third more energy by 2040 to power growing prosperity and lift two-and-a-half billion people out of low incomes.
And at the same time, that energy has to help reduce greenhouse gas emissions to something like half of what they are today.
Some might think there's no way that can be done with oil and gas in the mix.
They think our industry has had its day and now it's time for different forms of energy to take over.
I don't think that's the best answer.
Our industry can and must be part of the solution.
The world is depending on all of us.
I don't say that in a boastful way.
We've proven we can adapt and change over the years and we've overcome many big challenges along the way.
In fact, we've just recovered from one of the most protracted oil price downturns there has ever been by changing how we do business in two fundamental ways.
We got much more disciplined on costs and we're making dramatic improvements in efficiency through the use of digital and data.
As a result, we're leaner, fitter and better balanced at 60 dollars than we were at a hundred – and we're a more modern, more agile industry.
I really believe we're better positioned for the energy transition because of that.
By the way, we'd better be because it's already happening.
Our latest BP Energy Outlook says we could be heading for the most diverse fuel mix there's ever been - quarter-shares each for oil, gas and coal, and the other quarter coming from renewables and nuclear.
One implication of this transition is a declining share for oil.
There's a common misconception about that.
If you believe some of the things you read, the way to a low emissions world is through electric vehicles killing off the oil industry.
That has generated a lot of talk about oil demand peaking – but importantly, this does not imply a steep decline.
Yes, at some point oil will stop growing. But the pace of any subsequent decline is likely to be very slow, with the world needing a lot of oil for a long time to come.
You can see why that's the case when you look at a really extreme scenario.
That's what our chief economist, Spencer Dale, did in the Outlook, when he modelled what would happen if there was a worldwide ban on all new sales of traditional combustion engine cars by 2040.
Even in that extreme case, oil demand overall could still be higher in 20 years' time than it is now, up at around 100 million barrels a day.
And there's another remarkable side to that calculation.
It shows even a worldwide ban like that barely moves the dial on greenhouse gas emissions.
Emissions would still go up 7% by 2040 – not far off the 10% rise projected if the world continues on the course it's on today – and much higher than the near-50% fall thought necessary to be on course for the Paris climate goals.
Just to be clear, I'm not trying to discredit EVs.
They have a really important role to play, particularly in urban areas where they can improve air quality, and we see tremendous business opportunities for BP. Not just in EVs but in the broader revolution in mobility that's underway.
The important point here is that EVs are not the silver bullet that everyone is looking for.
The reality is that there is no silver bullet to reduce emissions.
But as our chief economist likes to say, if you want to make a really serious difference on carbon emissions from energy start by talking about the power sector, then go on talking about the power sector, then talk some more about the power sector.
We've seen that already here in the US.
Replacing coal with gas in power generation has helped to bring US emissions levels back down to where they were in the early 1990s.
That shows what gas can do – and the same needs to happen in the power sector more widely, particularly in Asia.
CCUS can also drive emissions down, in the power sector and elsewhere, and we are seeing more support from both sides of the Atlantic.
And in case anyone thinks I'm just an apologist for oil and gas, let me give you another projection from our Outlook.
Renewables are growing faster than any fuel in history - 5 times faster than gas.
That makes them a really exciting investment prospect – particularly where you can partner wind and solar with gas to counter the intermittency issues.
Yet even in one of the most aggressive growth scenarios for renewables, a course consistent with meeting the Paris goals, the world could still be sourcing around 40% of its energy from oil and gas.
What we take from this, and 20 years of low carbon experience going back to our Beyond Petroleum days, is that a race to renewables will not solve the dual challenge.
Instead, we need to be agnostic about fuels and focused on a race to lower emissions.
We've also learned another thing.
We can make alternative energy work.
We're one of the top generators of wind power here in the US and combined with our biofuels business in Brazil that makes us the largest operator of renewables among our peers.
And now we're back in solar in a new way.
But to really help make a difference on this important issue we need to do more than that – so we're infusing a lower carbon mindset in everything we do, right across the whole of BP.
We have a really simple but not simplistic framework to describe this approach.
We call it R – I – C, or RIC.
The R is for reducing emissions in our operations, which means producing oil and gas more efficiently and clamping down on methane leaks.
We're targeting sustainable reductions aggressively – and we'll be disclosing our targets next month so everyone can see what we're aiming to do.
We're also looking at how we design new projects, as we've just done in Oman at our giant Khazzan gas project.
We built a single, state-of-the-art processing plant there which minimises the potential for leaks from processing gas at each of the well sites.
So that's the R, reduce emissions.
The I in RIC is for improving our products in ways that can help our customers limit their emissions.
That means producing more natural gas as an alternative to coal in the power sector, producing more renewable fuels and developing more advanced fuels and lubricants that help engines run more efficiently.
And the C is for creating lower carbon businesses – expanding our existing ones and making a wide range of smart investments in promising technologies and ideas with the potential to be big breakthroughs.
We're backing up our actions with about a half-a-billion dollars of investment every year, and we're prepared to spend much more as we find and help develop real opportunities that are scalable.
So, Reduce emissions, Improve our products and Create new business models.
We believe this is the right approach for us, for our customers, our partners and our investors. But I'm not standing here saying it's right for everyone.
and Saudi Aramco is working on multiple technologies.
That's just a few examples.
We're all trying lots of exciting new things and partnering in different ways.
There's no one solution and I'm personally really encouraged that we are all so engaged.
But as much as we are doing, we need others to act as well.
We need all sectors of the economy to bring emissions down – and consumers as well.
We need a big drive on energy efficiency in all kinds of areas – that's where the greatest reductions are going to come from.
And we need governments to put a price on carbon.
Do that and you incentivise lower carbon activities of all kinds, right across the economy, including energy efficiency and carbon capture.
That would enable us to do a whole lot more. But as I hope I've made clear, we're not waiting for that. We're busy pursuing low carbon right now and we've got some really interesting plans to announce soon.
I've already mentioned targets, but we'll have other things to share as well.


The misoprostol can be administered buccally (in the cheek), sublingually (under the tongue), or vaginally. A growing body of research indicates that both medications can be taken from home, timed to a woman's particular life circumstances. However, many countries regulate the process such that mifepristone (and sometimes misoprostol) must be taken in a clinic. A follow-up visit with a... Buccally: If you are consuming Misoprostol pill or Cytotec pill buccally then you need to use 4 pills of this pregnancy termination and keep them in your cheek pouches so that they can be dissolved in the mouth and then the leftover granules should be gulped with water.
15, 16) Misoprostol with minimum doses of 25 mcg administered orally, vaginally, sublingually, or buccally was compared to prostaglandin E2 in a systematic review, which concluded that misoprostol, compared to prostaglandin E2, was associated with increased risks of tachysystole and hyperstimulation, high rates of vaginal delivery within 24 hours, low rates of oxytocin use, and increased... Buccally: If you are consuming Misoprostol pill or Cytotec pill buccally then you need to use 4 pills of this pregnancy termination and keep them in your cheek pouches so that they can be dissolved in the mouth and then the leftover granules should be gulped with water.
Plain language summary. Not enough evidence to say if misoprostol administered under the tongue or in the cheek is safe for induction of labour. Sometimes labour is started artificially (induction) because of concerns for the well‐being of either the baby or the mother. misoprostol 200 mcg how to use The pregnant woman received 3 doses of misoprostol 800 µg administered buccally 12 hours apart in the first trimester for abortion. Subsequently, she experienced excessive vomiting, which was considered to be related to misoprostol. The vomiting resolved without the need of further intervention.
Misoprostol can be given orally, buccally (dissolved between the gums and cheek), or vaginally. Many doctors are only giving misoprostol by mouth because of reports of a rare, fatal infection that affected a few women after using vaginal misoprostol. Experts do not know for sure if these deaths were related to the use of vaginal misoprostol.
Mifepristone is used in combination with misoprostol (Cytotec) to end an early pregnancy. Early pregnancy means it has been 70 days or less since your last menstrual period began.


Rebecca Mascull is the author of three historical novels, all published by Hodder & Stoughton.
Her first novel, THE VISITORS, tells the story of Adeliza Golding, a deaf-blind child living on her father's hop farm in Victorian Kent. Her second novel SONG OF THE SEA MAID is set in the C18th and concerns an orphan girl who becomes a scientist and makes a remarkable discovery. Her third novel, THE WILD AIR, is about a shy Edwardian girl who learns to fly and becomes a celebrated aviatrix but the shadow of war is looming.
She has also recently completed the final chapters of her friend and fellow novelist Vanessa Lafaye's final work, a novella called MISS MARLEY, a prequel to Dickens's A CHRISTMAS CAROL. This novella will be published in November 2018 by HarperCollins.
After previously working in education, Rebecca is now a full-time writer. She has a Masters in Writing and lives by the sea in the East of England. Rebecca also writes sagas under the pen-name Mollie Walton.
Against the conventions of the day, and to the alarm of her male contemporaries, she sets sail to Portugal to develop her theories. There she makes some startling discoveries - not only in an ancient cave whose secrets hint at a previously undiscovered civilisation, but also in her own heart. The siren call of science is powerful, but as war approaches she finds herself pulled in another direction by feelings she cannot control.
Adeliza Golding is a deafblind girl, born in late Victorian England on her father's hop farm. Unable to interact with her loving family, she exists in a world of darkness and confusion; her only communication is with the ghosts she speaks to in her head, who she has christened the Visitors. One day she runs out into the fields and a young hop-picker, Lottie, grabs her hand and starts drawing shapes in it. Finally Liza can communicate.
Before A CHRISTMAS CAROL there was… Miss Marley. A seasonal tale of kindness and goodwill.


A lavishly illustrated, freshly conceived tarot deck and guidebook that focuses on creative inspiration, daily reflection, and revealing new possibilities.
Move your creativity and life forward with this gorgeously designed deck. The Fountain Tarot draws on tradition, but provides a modern voice and distinct approach that highlights our everyday lives as a source of insight, wisdom, and growth.
As a daily tool for reflection and a powerful vehicle for self-discovery, The Fountain Tarot reveals creative opportunities, awakens fresh viewpoints, and offers a new take on life's possibilities. Whether you're selecting a card to set the tone for your day, invigorate your creative energy, or inspire you before your meditation or yoga practice, The Fountain Tarot helps open closed doors and reveal new paths.
JONATHAN SAIZ's paintings and sculptures are in private and commercial collections worldwide and are exhibited in the US and the UK. His last series, ALKAHEST, was created during eight hermetic months on the Greek island of Mykonos. A recent commission from the Denver Museum of Nature and Science allowed him to explore his interest in the shrouded and mysterious side of history, studying ancient Roman frescoes and scarab beetles, also expanding his love for the visual and energetic possibilities of crystals and minerals.
JASON GRUHL is the former executive director and founder of The Joshua School (a school for children with Autism Spectrum Disorders and Developmental Disabilities in Boulder and Denver, CO) and an educational consultant. Jason holds a Master's degree in Counseling Psychology and a Bachelor's degree in English and Psychology, and dedicates his life to self-discovery through meditation and reflection.
ANDI TODARO's graphic design projects have taken her across the US and into Europe: from her recent work with MSNBC in NYC for their coverage of "The Feast," to her designs for the "Belle Epoque" and "Bollywood" Galas of the American School of Paris.
This one was wonderful. It's been some time since I picked up a book about the Tarot and this one was a hit. I've been working with the Tarot for over 20 years and I have to say that this one was very good. It is a wonderful first step into finding new insights and finding a new path. The book was a very easy read and easy to follow. Although this is just a review of the book itself. If you go to Amazon you will be able to see what the cards look like and I have to tell you they are amazing and beautiful!!


The development of viral cultures in chicken embryos and mice by Koprowski and Cox in the 1940s and subsequent refinements in viral isolation and molecular biology permitted further description of Colorado tick fever virus (CTFV). Much is now known about its ecological niche and life cycle in vertebrate and invertebrate hosts as well as the epidemiology, pathogenesis, and clinical course of infection in humans. The current taxonomy recognizes three distinct species: (i) the type species, Banna virus (BAV); (ii) Kadipiro virus; and (iii) Liao Ning virus. The pathogenic potential of these viruses in humans remains to be determined, although associations of BAV infection with febrile illnesses and encephalitis are convincing. Seadornaviruses are serologically distinct from CTFV and Eyach virus (EYAV), have a lower G+C content than coltiviruses, and show genetic distances in the RNA-dependent RNA polymerase of more than 90% compared to coltiviruses. The genome of all members of the Reoviridae consists of segmented double-stranded RNA (dsRNA). Electron microscopic (EM) studies of cultured cells following infection reveal viral particles in association with granular matrices within the cytoplasm. The name Orbivirus derives from the appearance of virus particles as large, doughnut-shaped capsomeres by negative-contrast EM. Though the most-studied orbiviruses are agents of veterinary import, a number of serogroups within the genus cause human disease. They are predominantly transmitted by arthropod vectors.
1. Andersen, R. D.,, M. A. Entringer, and, W. A. Robinson. 1985. Virus-induced leukopenia: Colorado tick fever as a human model. J. Infect. Dis. 151: 449– 453.
2. Ater, J. L.,, J. C. Overall, Jr.,, T. J. Yeh,, R. T. O'Brien, and, A. Bailey. 1985. Circulating interferon and clinical symptoms in Colorado tick fever. J. Infect. Dis. 151: 966– 968.
3. Attoui, H.,, F. Billoir,, P. Biagini,, J. F. Cantaloube,, R. de Chesse,, P. de Micco, and, X. de Lamballerie. 2000. Sequence determination and analysis of the full-length genome of Colorado tick fever virus, the type species of genus Coltivirus (family Reoviridae). Biochem. Biophys. Res. Commun. 273: 1121– 1125.
4. Attoui, H.,, F. Billoir,, P. Biagini,, P. de Micco, and, X. de Lamballerie. 2000. Complete sequence determination and genetic analysis of Banna virus and Kadipiro virus: proposal for assignment to a new genus (Seadornavirus) within the family Reoviridae. J. Gen. Virol. 81 (Pt. 6) : 1507– 1515.
5. Attoui, H.,, F. Billoir,, J. M. Bruey,, P. de Micco, and, X. de Lamballerie. 1998. Serologic and molecular diagnosis of Colorado tick fever viral infections. Am. J. Trop. Med. Hyg. 59: 763– 768.
6. Attoui, H.,, R. N. Charrel,, F. Billoir,, J. F. Cantaloube,, P. de Micco, and, X. de Lamballerie. 1998. Comparative sequence analysis of American, European and Asian isolates of viruses in the genus Coltivirus. J. Gen. Virol. 79 (Pt. 10 ): 2481– 2489.
7. Attoui, H.,, F. Mohd Jaffar,, P. de Micco, and, X. de Lamballerie. 2005. Coltiviruses and Seadornaviruses in North America, Europe, and Asia. Emerg. Infect. Dis. 11: 1673– 1679.
8. Bakken, J. S.,, J. S. Dumler,, S. M. Chen,, M. R. Eckman,, L. L. Van Etta, and, D. H. Walker. 1994. Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA 272: 212– 218.
9. Bakken, J. S.,, J. Krueth,, C. Wilson-Nordskog,, R. L. Tilden,, K. Asanovich, and, J. S. Dumler. 1996. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 275: 199– 205.
10. Becker, F. E. 1930. Tick borne infections in Colorado. Colo. Med. 27: 87– 95.
11. Billoir, F.,, H. Attoui,, S. Simon,, P. Gallian,, P. deMicco, and, X. de Lamballerie. 1999. Molecular diagnosis of group B coltivirus infections. J. Virol. Methods 81: 39– 45.
12. Bodkin, D. K.,, and D. L. Knudson. 1987. Genetic relatedness of Colorado tick fever virus isolates by RNARNA blot hybridization. J. Gen. Virol. 68 (Pt. 4) : 1199– 1204.
13. Bowen, G. S. 1988. Colorado tick fever, p. 159–176. In T. P. Monath (ed.), The Arboviruses: Ecology and Epidemiology. CRC Press, Boca Raton, FL.
14. Bratton, R.,, and G. Corey. 2005. Tick-borne disease. Am. Family Physician 71: 2323– 2330.
15. Brown, S. E.,, B. R. Miller,, R. G. McLean, and, D. L. Knudson. 1989. Co-circulation of multiple Colorado tick fever virus genotypes. Am. J. Trop. Med. Hyg. 40: 94– 101.
16. Brown, S. E.,, H. G. Morrison,, N. Karabatsos, and, D. L. Knudson. 1991. Genetic relatedness of two new Orbivirus serogroups: Orungo and Lebombo. J. Gen. Virol. 72(Pt. 5) : 1065– 1072.
17. Burgdorfer, W. 1959. Colorado tick fever. The behavior of Colorado tick fever virus in the porcupine. J. Infect. Dis. 104: 101– 104.
18. Burgdorfer, W. 1960. Colorado tick fever. The behavior of Colorado tick fever virus in rodents. J. Infect. Dis. 107: 384– 388.
19. Calisher, C. H. 1994. Medically important arboviruses of the United States and Canada. Clin. Microbiol. Rev. 7: 89– 116.
20. Centers for Disease Control and Prevention. 1995. Human granulocytic ehrlichiosis—New York, 1995. Morb. Mortal. Wkly. Rep. 44: 593– 595.
21. Chao, L. 1994. Evolution of genetic exchange in RNA viruses, p. 233–250. In S. S. Morse (ed.), The Evolutionary Biology of Viruses. Raven Press, Ltd., New York, NY.
22. Chastel, C.,, A. J. Main,, A. Couatarmanac'h,, G. Le Lay,, D. L. Knudson,, M. C. Quillien, and, J. C. Beaucournu. 1984. Isolation of Eyach virus ( Reoviridae, Colorado tick fever group) from Ixodes ricinus and I. ventalloi ticks in France. Arch. Virol. 82: 161– 171.
23. Chen, B. Q.,, and S. J. Tao. 1996. Arbovirus survey in China in recent ten years. Chin. Med. J. 109: 13– 15.
24. Chumakov, M. P.,, L. G. Karpovich,, E. S. Sarmanova,, G. I. Sergeeva,, M. B. Bychkova,, V. O. Tapupere,, H. Libikova,, V. Mayer,, J. Rehacek,, O. Kozuch, and, E. Ernek. 1963. Report on the isolation from Ixodes persulcatus ticks and from patients in western Siberia of a virus differing from the agent of tick-borne encephalitis. Acta Virol. 7: 82– 83.
25. Craven, R. B. 1991. Orbiviruses and other reoviruses, p. 713–718. In R. B. Belshe (ed.), Textbook of Human Virology. Mosby-Year Book, Inc., St. Louis, MO.
26. Dawson, D. L.,, and T. M. Vernon. 1972. Colorado tick fever—Colorado. Morb. Mortal. Wkly. Rep. 21: 374.
27. Dawson, J. E.,, C. K. Warner,, S. Standaert, and, J. G. Olson. 1996. The interface between research and the diagnosis of an emerging tick-borne disease, human ehrlichiosis due to Ehrlichia chaffeensis. Arch. Intern. Med 156: 137– 142.
28. Draughn, D. E.,, O. F. Sieber, Jr., and, J. H. Umlauf, Jr. 1965. Colorado tick fever encephalitis. Clin. Pediatr. 4: 626– 628.
29. Eklund, C. M.,, G. M. Kohls, and, W. L. Jellison. 1958. Isolation of Colorado tick fever virus from rodents in Colorado. Science 128: 413.
30. Eklund, C. M.,, G. M. Kohls,, W. L. Jellison,, W. Burgdorfer,, K. C. Kennedy, and, L. Thomas. 1959. The clinical and ecological aspects of Colorado tick fever, p. 197–203. In Proc. 6th Int. Conf. Trop. Med. Malaria, vol. 5. Instituto de Medicinia Tropical, Lisbon, Portugal.
31. Emmons, R. W. 1981. Colorado tick fever, p. 113–124. In J. H. Steele (ed.), CRC Handbook on Zoonoses. CRC Press, Boca Raton, FL.
32. Emmons, R. W. 1988. Ecology of Colorado tick fever. Annu. Rev. Microbiol. 42: 49– 64.
33. Emmons, R. W.,, D. V. Dondero,, V. Devlin, and, E. H. Lennette. 1969. Serologic diagnosis of Colorado tick fever. A comparison of complement-fixation, immunofluorescence, and plaque-reduction methods. Am. J. Trop. Med. Hyg. 18: 796– 802.
34. Emmons, R. W.,, and E. H. Lennette. 1966. Immunofluorescent staining in the laboratory diagnosis of Colorado tick fever. J. Lab. Clin. Med. 68: 923– 929.
35. Emmons, R. W.,, L. S. Oshiro,, H. N. Johnson, and, E. H. Lennette. 1972. Intra-erythrocytic location of Colorado tick fever virus. J. Gen. Virol. 17: 185– 195.
36. Emmons, R. W.,, and H. I. Schade. 1972. Colorado tick fever simulating acute myocardial infarction. JAMA 222: 87– 88.
37. Eng, T. R.,, J. R. Harkess,, D. B. Fishbein,, J. E. Dawson,, C. N. Greene,, M. A. Redus, and, F. T. Satalowich. 1990. Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988. JAMA 264: 2251– 2258.
38. Fabiyi, A.,, O. Tomori, and, M. S. el Bayoumi. 1975. Epidemics of a febrile illness associated with UgMP 359 virus in Nigeria. West Afr. Med. J. Niger. Med. Dent. Pract. 23: 9– 11.
39. Familusi, J. B.,, D. L. Moore,, A. K. Fomufod, and, O. R. Causey. 1972. Virus isolates from children with febrile convulsions in Nigeria. A correlation study of clinical and laboratory observations. Clin. Pediatr. 11: 272– 276.
40. Fishbein, D. B.,, J. E. Dawson, and, L. E. Robinson. 1994. Human ehrlichiosis in the United States, 1985 to 1990. Ann. Intern. Med. 120: 736– 743.
41. Florio, L.,, M. Stewart, and, E. R. Mugrage. 1944. The experimental transmission of Colorado tick fever. J. Exp. Med. 80: 165– 187.
42. Forzan, M.,, M. Marsch, and, P. Roy. 2007. Bluetongue virus entry into cells. J. Virol. 81: 4819– 4827.
43. Francki, R. I. B.,, C. M. Fauquet,, D. L. Knudson, and, F. Brown. 1991. Classification and nomenclature of viruses. Arch. Virol. Suppl. 2: 186.
44. Goodman, J. L.,, C. Nelson,, B. Vitale,, J. E. Madigan,, J. S. Dumler,, T. J. Kurtti, and, U. G. Munderloh. 1996. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N. Engl. J. Med. 334: 209– 215.
45. Goodpasture, H. C.,, J. D. Poland,, D. B. Francy,, G. S. Bowen, and, K. A. Horn. 1978. Colorado tick fever: clinical, epidemiologic, and laboratory aspects of 228 cases in Colorado in 1973–1974. Ann. Intern. Med. 88: 303– 310.
46. Green, I. J. 1970. Evidence for the double-stranded nature of the RNA of Colorado tick fever virus, an un-grouped arbovirus. Virology 40: 1056– 1059.
47. Hadlow, W. J. 1957. Histopathologic changes in suckling mice infected with the virus of Colorado tick fever. J. Infect. Dis. 101: 158– 167.
48. Hierholzer, W. J.,, and D. W. Barry. 1971. Colorado tick fever pericarditis. JAMA 217: 825.
49. ICTVdB Management. 2006. 00.060.0.04.001. Colorado tick fever virus. In C. Büchen-Osmond (ed.), ICTVdB—The Universal Virus Database, version 4. Columbia University, New York, NY. http://www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/.
50. ICTVdB Management. 2006. 00.060.0.02. Orbivirus. In C. Büchen-Osmond (ed.), ICTVdB—The Universal Virus Database, version 4. Columbia University, New York, NY. http://www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/.
51. ICTVdB Management. 2006. 00.060.0.10. Seadornavirus. In C. Büchen-Osmond (ed.), ICTVdB—The Universal Virus Database, version 4. Columbia University, New York, NY. http://www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/.
52. Johnson, A. J.,, N. Karabatsos, and, R. S. Lanciotti. 1997. Detection of Colorado tick fever virus by using reverse transcriptase PCR and application of the technique in laboratory diagnosis. J. Clin. Microbiol. 35: 1203– 1208.
53. Karabatsos, N.,, J. D. Poland,, R. W. Emmons,, J. H. Mathews,, C. H. Calisher, and, K. L. Wolff. 1987. Antigenic variants of Colorado tick fever virus. J. Gen. Virol. 68 (Pt. 5) : 1463– 1469.
54. Knudson, D. L. 1981. Genome of Colorado tick fever virus. Virology 112: 361– 364.
55. Knudson, D. L.,, and T. P. Monath. 1990. Orbiviruses, p. 1405–1433. In B. N. Fields and, D. M. Knipe (ed.), Virology. Raven Press, Ltd., New York, NY.
56. Koprowski, H.,, and H. R. Cox. 1946. Adaptation of Colorado tick fever virus to mice and developing chick embryo. Proc. Soc. Exp. Biol. Med. 62: 320– 322.
57. Lambert, A. J.,, O. Kosoy,, J. O. Velez,, B. J. Russell, and, R. S. Lanciotti. 2007. Detection of Colorado tick fever viral RNA in acute human serum samples by a quantitative RT-PCR assay. J. Virol. Meth. 140: 43– 48.
58. Lane, R. S.,, R. W. Emmons,, V. Devlin,, D. V. Dondero, and, B. C. Nelson. 1982. Survey for evidence of Colorado tick fever virus outside of the known endemic area in California. Am. J. Trop. Med. Hyg. 31: 837– 843.
59. Li, Q. P.,, S. C. Hsiah,, C. Zhie,, L. Ma,, B. L. Ah,, Y. O. Lin,, S. B. Wu,, Y. J. Zhang,, E. K. Yah,, C. Wang,, L. M. Se,, G. D. Yan,, Y. Ho,, Z. J. Zhao,, B. C. Chen,, P.-T. Shu, and, J. M. Zuo. 1992. First isolations of 8 strains of new orbivirus (BANNA) from patients with innominate fever in Xinjiang. Endem. Dis. Bull. 7: 77– 81.
60. Libikova, H.,, F. Heinz,, D. Ujhazyova, and, D. Stunzner. 1978. Orbiviruses of the Kemerovo complex and neurological diseases. Med. Microbiol. Immunol. 166: 255– 263.
61. Loge, R. V. 1985. Acute hepatitis associated with Colorado tick fever. West. J. Med. 142: 91– 92.
62. Malkova, D.,, J. Holubova,, J. M. Kolman,, Z. Marhoul,, F. Hanzal,, H. Kulkova,, K. Markvart, and, L. Simkova. 1980. Antibodies against some arboviruses in persons with various neuropathies. Acta Virol. 24: 298.
63. Mertens, P. P. C.,, R. Duncan,, H. Attoui, and, T. S. Dermody. 2005. Reoviridae, p. 447–454. In C. M. Fauquet,, M. A. Mayo,, J. Maniloff,, U. Desselberger, and, L. A. Ball (ed.), Virus Taxonomy: Classification and Nomenclature of Viruses. Eighth Report of the International Committee on Taxonomy of Viruses. Elsevier/Academic Press, San Deigo, CA.
64. Miller, J. K.,, V. N. Tompkins, and, J. C. Sieracki. 1961. Pathology of Colorado tick fever in experimental animals. Arch. Pathol. 72: 149– 157.
65. Mohd Jaafar, F.,, H. Attoui,, M. W. Bahar,, C. Siebold,, G. Sutton,, P. P. Mertens,, P. De Micco,, D. I. Stuart,, J. M. Grimes, and, X. De Lamballerie. 2005. The structure and function of the outer coat protein VP9 of Banna virus. Structure 13: 17– 28.
66. Mohd Jaafar, F.,, H. Attoui,, P. De Micco, and, X. De Lamballerie. 2004. Recombinant VP6-based enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Eyach virus (genus Coltivirus). J. Clin. Virol. 30: 248– 253.
67. Mohd Jaafar, F.,, H. Attoui,, P. De Micco, and, X. De Lamballerie. 2004. Termination and read-through proteins encoded by genome segment 9 of Colorado tick fever virus. J. Gen. Virol. 85(Pt. 8) : 2237– 2244.
68. Mohd Jaafar, F.,, H. Attoui,, P. Gallian,, I. Isahak,, K. T. Wong,, S. K. Cheong,, V. S. Nadarajah,, J. F. Cantaloube,, P. Biagini,, P. De Micco, and, X. De Lamballerie. 2004. Recombinant VP9-based enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Banna virus (genus Seadornavirus). J. Virol. Methods 116: 55– 61.
69. Mohd Jaafar, F.,, H. Attoui,, P. P. Mertens,, P. de Micco, and, X. de Lamballerie. 2005. Identification and functional analysis of VP3, the guanyltransferase of Banna virus (genus Seadornavirus, family Reoviridae). J. Gen. Virol. 86(Pt. 4) : 1141– 1146.
70. Mohd Jaafar, F.,, H. Attoui,, P. P. C. Mertens,, P. deMicco, and, X. de Lamballerie. 2005. Structural organization of an encephalitic human isolate of Banna virus (genus Seadornavirus, family Reoviridae). J. Gen. Virol. 86: 1147– 1157.
71. Monath, T. P. 1995. Colorado tick fever, p. 1446–1447. In G. L. Mandell,, J. E. Bennett, and, R. Dolin (ed.), Principles and Practice of Infectious Diseases, 4th ed. Churchill Livingstone, New York, NY.
72. Monath, T. P.,, R. B. Craven,, A. Adjukiewicz,, M. Germain,, D. B. Francy,, L. Ferrara,, E. M. Samba,, H. N'Jie,, K. Cham,, S. A. Fitzgerald,, P. H. Crippen,, D. I. Simpson,, E. T. Bowen,, A. Fabiyi, and, J. J. Salaun. 1980. Yellow fever in the Gambia, 1978–1979: epidemiologic aspects with observations on the occurrence of orungo virus infections. Am. J. Trop. Med. Hyg. 29: 912– 928.
73. Moore, D. L.,, O. R. Causey,, D. E. Carey,, S. Reddy,, A. R. Cooke,, F. M. Akinkugbe,, T. S. David-West, and, G. E. Kemp. 1975. Arthropod-borne viral infections of man in Nigeria, 1964–1970. Ann. Trop. Med. Parasitol. 69: 49– 64.
74. Murphy, F. A.,, E. C. Borden,, R. E. Shope, and, A. Harrison. 1971. Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus—a new taxonomic group. Electron microscopic studies. J. Gen. Virol. 13: 273– 288.
75. Murphy, F. A.,, P. H. Coleman,, A. K. Harrison, and, G. W. Gary, Jr. 1968. Colorado tick fever virus: an electron microscopic study. Virology 35: 28– 40.
76. Murphy, F. A.,, C. M. Fauquet,, D. H. L. Bishop,, S. A. Ghabrial,, A. W. Jarvis,, G. P. Martelli,, M. A. Mayo, and, M. D. Summers (ed.). 1995. Virus Taxonomy: Classification and Nomenclature of Viruses. Sixth Report of the International Committee on Taxonomy of Viruses. Springer-Verlag, Vienna, Austria.
77. Oshiro, L. S.,, D. V. Dondero,, R. W. Emmons, and, E. H. Lennette. 1978. The development of Colorado tick fever virus within cells of the haemopoietic system. J. Gen. Virol. 39: 73– 79.
78. Oshiro, L. S.,, and R. W. Emmons. 1968. Electron microscopic observations of Colorado tick fever virus in BHK 21 and KB cells. J. Gen. Virol. 3: 279– 280.
79. Philipp, C. S.,, C. Callaway,, M. C. Chu,, G. H. Huang,, T. P. Monath,, D. Trent, and, B. L. Evatt. 1993. Replication of Colorado tick fever virus within human hematopoietic progenitor cells. J. Virol. 67: 2389– 2395.
81. Randall, W. H.,, J. Simmons,, E. A. Caspter, and, R. N. Philip. 1975. Transmission of Colorado tick fever virus by blood transfusion—Montana. Morb. Mortal. Wkly. Rep. 24: 422– 427.
82. Rehse-Kupper, B.,, J. Casals,, E. Rehse, and, R. Ackermann. 1976. Eyach—an arthropod-borne virus related to Colorado tick fever virus in the Federal Republic of Germany. Acta Virol. 20: 339– 342.
83. Roy, P. 1993. Dissecting the assembly of orbiviruses. Trends Microbiol. 1: 299– 305.
85. Smee, D. F.,, J. L. Morris,, D. L. Barnard, and, A. Van Aerschot. 1992. Selective inhibition of arthropod-borne and arenaviruses in vitro by 3′-fluoro-3′-deoxyadenosine. Antivir. Res. 18: 151– 162.
86. Smee, D. F.,, R. W. Sidwell,, S. M. Clark,, B. B. Barnett, and, R. S. Spendlove. 1981. Inhibition of bluetongue and Colorado tick fever orbiviruses by selected antiviral substances. Antimicrob. Agents Chemother. 20: 533– 538.
88. Spach, D. H.,, W. C. Liles,, G. L. Campbell,, R. E. Quick,, D. E. Anderson, Jr., and, T. R. Fritsche. 1993. Tickborne diseases in the United States. N. Engl. J. Med. 329: 936– 947.
89. Spruance, S. L.,, and A. Bailey. 1973. Colorado tick fever. A review of 115 laboratory confirmed cases. Arch. Intern. Med. 131: 288– 293.
90. Swanepoel, R.,, B. J. Erasmus,, R. Williams, and, M. B. Taylor. 1992. Encephalitis and chorioretinitis associated with neurotropic African horsesickness virus infection in laboratory workers. Part III. Virological and serological investigations. S. Afr. Med. J. 81: 458– 461.
91. Tao, S. J.,, and B. Q. Chen. 2005. Studies of Coltivirus in China. Chin. Med. J. (Engl. Ed.) 118: 581– 586.
92. Telford, S. R.,, III, T. J. Lepore,, P. Snow,, C. K. Warner, and, J. E. Dawson. 1995. Human granulocytic ehrlichiosis in Massachusetts. Ann. Intern. Med. 123: 277– 279.
93. Thomas, L. A.,, R. N. Philip,, E. Patzer, and, E. Casper. 1967. Long duration of neutralizing-antibody response after immunization of man with a formalinized Colorado tick fever vaccine. Am. J. Trop. Med. Hyg. 16: 60– 62.
94. Tomori, O.,, and A. Fabiyi. 1976. Neutralizing antibodies to Orungo virus in man and animals in Nigeria. Trop. Geogr. Med. 28: 233– 238.
95. Topping, H. N. 1940. Colorado tick fever. Public Health Rep. 55: 2224– 2237.
96. Travassos da Rosa, A. P.,, R. B. Tesh,, F. P. Pinheiro,, J. F. Travassos da Rosa,, P. H. Peralta, and, D. L. Knudson. 1984. Characterization of the Changuinola sero-group viruses (Reoviridae: Orbivirus). Intervirology 21: 38– 49.
97. Trent, D. W.,, and L. V. Scott. 1966. Colorado tick fever virus in cell culture. II. Physical and chemical properties. J. Bacteriol. 91: 1282– 1288.
98. Tsai, T. F. 1991. Arboviral infections in the United States. Infect. Dis. Clin. N. Am. 5: 73– 102.
99. Tsai, T. F. 2005. Coltiviruses and Seadornaviruses (Colorado tick fever), p. 1900–1901. In G. L. Mandell,, J. E. Bennett, and, R. Dolin (ed.), Principles and Practice of Infectious Diseases. Churchill Livingstone, Philadelphia, PA.
100. Tsai, T. F. 2005. Orthoreoviruses and Orbiviruses, p. 1899–1900. In G. L. Mandell,, J. E. Bennett, and, R. Dolin (ed.), Principles and Practice of Infectious Diseases, 6th ed. Churchill Livingstone, Philadelphia, PA.
101. van der Meyden, C. H.,, B. J. Erasmus,, R. Swanepoel, and, O. W. Prozesky. 1992. Encephalitis and chorioretinitis associated with neurotropic African horsesickness virus infection in laboratory workers. Part I. Clinical and neurological observations. S. Afr. Med. J. 81: 451– 454.
102. Walker, D. H.,, and S. J. Dumler. 2000. Ehrlichia chaffeensis (human monocytotropic ehrlichiosis), Ehrlichia phagocytophila (human granulocytotropic ehrlichiosis), and other Ehrlichia, p. 2057–2064. In G. L. Mandell,, J. E. Bennett, and, R. Dolin (ed.), Principles and Practice of Infectious Diseases, 5th ed. Churchill Livingstone, Philadelphia, PA.
103. Wang, D.,, A. Urisman,, Y. T. Liu,, M. Springer,, T. G. Ksiazek,, D. D. Erdman,, E. R. Mardis,, M. Hickenbotham,, V. Magrini,, J. Eldred,, J. P. Latreille,, R. K. Wilson,, D. Ganem, and, J. L. DeRisi. 2003. Viral discovery and sequence recovery using DNA microarrays. PLoS Biol. 1 (2) : E2.


text:
Peter T. Nicholl
William C. Burgy
Caitlin K. Carpenter
William Beveridge, Jr.
Kevin P. Bilms
Thomas F. Burris, III
Benjamin L. Davis, III
Michael T. Edmonds
Scott E. Nevin
George E. Swegman
John M. Williams, Jr.
Michael A. Brown
Kelly A. Burgy
Jonathan A. Cusson
Molly A. Nicholl
TestimonialsLearn More
"This office has been handling my case for asbestos damage. Very professional and responsible."
– L.B., asbestos client in Baltimore, MD
Our Areas of Practice Learn More
Lead Paint Poisoning
Mesothelioma & Asbestos Diseases
36 South Charles Street, Suite 1700, Baltimore, MD 21201
355 Crawford Street Portsmouth, VA 23704
You don't pay unless we win a recovery for you.
Our Areas of PracticeLearn More
Pradaxa Lawsuit
The class action attorneys at The Law Offices of Peter T. Nicholl are reviewing claims on behalf of patients who were prescribed the blood thinner Pradaxa and suffered severe bleeding events, including gastrointestinal bleeds and cerebral hemorrhaging.
Thousands of patients have filed lawsuits against Pradaxa's manufacturer, Boehringer Ingelheim Pharmaceuticals, Inc., for the pain and suffering they endured after taking the drug.
If you or someone you love suffered a severe bleeding event after taking Pradaxa, contact The Law Offices of Peter T. Nicholl for a free, no obligation consultation. We are qualified personal injury attorneys with a history of success recovering millions in verdicts and settlements for our clients. Our attorneys will not hesitate to pursue all legal options available to help you recover the justice and compensation you deserve. We work only on a contingency fee basis, which means there are no fees or costs unless we recover for your claim.
Call 410-244-7005 to schedule a free consultation.
What is Pradaxa?
Pradaxa is an anticoagulant used to reduce the risk of stroke and blood clots in people who are diagnosed with a medical condition called atrial fibrillation, which is an irregular heart beat that causes poor blood flow. It is also prescribed to patients who suffer blood clots in the veins of their legs (deep vein thrombosis) or lungs (pulmonary embolism).
Pradaxa was approved by the U.S. Food and Drug Administration (FDA) and released in the U.S. in 2010. It was initially marketed as a safer and more convenient alternative to warfarin because Pradaxa did not require patients be monitored or follow a dietary plan. Warfarin is another anticoagulant that has been in circulation for more than 60 years and requires routine blood tests.
However, a 2015 study conduct by medical researchers at the University of Pittsburgh found that when compared to warfarin, Pradaxa patients suffered:
Thirty-eight percent more bleeding events
Fifty-eight percent more major bleeding events
Eighty-five percent more gastrointestinal bleeding events
Twenty-two percent less intracranial hemorrhaging events
Researchers used "real-world clinical practice" as opposed to carefully selecting subjects for clinical trials like Boerhinger Ingelheim during Pradaxa's testing stage. Using records from Medicare, researchers compared data from patients who had been diagnosed with atrial fibrillation and prescribed Pradaxa or warfarin. They concluded that health care providers should only prescribe Pradaxa with caution, especially with high-risk patients.
Complete a Free Case Evaluation form.
Pradaxa Side Effects
Blood clots are a natural mechanism of the body that help stop bleeding from an injury. By blocking a clotting enzyme called thrombin, Pradaxa reduces the body's ability to form clots and lessens the risk of a stroke.
Because they work to prevent the body from forming blood clots, all anticoagulants pose a risk of serious and fatal internal bleeding events. However, unlike other anticoagulants, Pradaxa was released without an antidote to reverse anti-clotting and stop uncontrollable bleeding events.
As a result, just one year after its release in the U.S. market, Pradaxa became the main suspect in 542 patient deaths reported to the FDA. The drug was soon linked to more reports of injury or death than any of the more than 800 drugs regulated by the Institute for Safe Medication Practices.
Patients who experienced adverse health events after taking Pradaxa often reported suffering:
Intracranial hemorrhaging
Abdominal pain and discomfort
Erosive gastritis
Gastric hemorrhage
Hemorrhagic gastritis
Hemorrhagic erosive
Gastrointestinal ulcer
Signs of these dangerous side effects include:
Unusual bruising or bleeding
Red or black stools
Red or brown urine
Vomiting that resembles coffee ground or blood
Coughing up blood
Frequent nosebleeds
Joint pain and swelling
Weakness and swelling on the hands, feet, arms, lower legs or ankles
Dizziness or disorientation
In 2012, the FDA began evaluating new information about the risk of serious bleeding associated with Pradaxa. In response, the FDA ordered a "black box warning" be added to all Pradaxa containers to caution patients and health care providers about risks associated with the drug.
In 2015, the FDA granted accelerated approval to a Boehringer Ingelheim-manufactured antidote to Pradaxa, called Praxbind (idarucizumab).
However, by that time the FDA's Adverse Event Reporting System database showed 973 reports of patient death related to Pradaxa. Approximately 9,000 patients had been hospitalized for internal bleeding.
Call 410-244-7005 if you or a loved one was harmed after taking Pradaxa.
Pradaxa Lawsuits
More than 4,000 patients have filed Pradaxa lawsuits against Boehringer Ingelheim, alleging the drug caused them to suffer damaging and life-threatening side effects.
The lawsuits claim the company misled patients and doctors about Pradaxa's risks and benefits compared to warfarin. Patients also allege Boehringer Ingelheim:
Falsely marketed Pradaxa as a safer and more efficient alternative to warfarin
Misled patients and health care providers to believe that Pradaxa did not require regular monitoring or check-ups to adjust dosage
Failed to adequately warn or disclose the risk of serious, excessive, uncontrollable or fatal bleeding events after taking Pradaxa
Neglected to adequately research Pradaxa's safety and establish variable factors in recommending doses of Pradaxa
Intentionally hid the dangers and risks associated with Pradaxa
Failed to uphold its obligation to warn consumers about risks of taking Pradaxa
Because of thousands of Pradaxa lawsuits were filed in federal court, most were consolidated into a single multidistrict litigation (MDL) in August 2012.
In February 2014, Boehringer Ingelheim stated that it had "carefully and responsibly" researched, developed and marketed Pradaxa. However, 2014 Bloomberg reports filed in Pradaxa litigation suggested Boehringer Ingelheim withheld data from the FDA showing that the drug exhibited internal bleeding side effects that were higher than expected.
In May 2014, the drug maker announced it would pay $650 million to settle the more than 4,000 state and federal Pradaxa lawsuits filed against it. By agreeing to a settlement, Boehringer Ingelheim continued to deny it had committed any negligence or wrongdoing.
Can I File a Pradaxa Lawsuit?
If your or a loved one was prescribed Pradaxa and suffered internal bleeding after taking the drug as directed, you may be entitled to compensation through a Pradaxa lawsuit.
Our skilled class action attorneys will provide you with a free, no obligation consultation to determine if you can file a Pradaxa lawsuit. If so, our attorneys will diligently pursue the makers of Pradaxa for compensation for:
Loss of earning capacity
Physical impairment
Pharmaceutical conglomerates like Boehringer Ingelheim have abundant financial and legal resources designed to protect them from lawsuits filed by patients harmed by their products.
For this reason, you will need a qualified and experienced attorney to represent you during a lawsuit, and one who has the knowledge and skills to negotiate a fair and reasonable outcome that reflects the pain and suffering you endured.
Do not hesitate to contact us to schedule a free consultation and find out if you are entitled to file a Pradaxa lawsuit against Boehringer Ingelheim.
Call 410-244-7005 to find out your legal options.
Contact an Experienced Attorney
If you believe you or someone you love suffered an uncontrollable bleeding event after being prescribed Pradaxa, immediately contact The Law Offices of Peter T. Nicholl to review your legal options.
Our attorneys will provide you with a free, no obligation consultation to help you determine if you have a case against Boehringer Ingelheim that will help you obtain justice and compensation.
At The Law Offices of Peter T. Nicholl, we believe that when a pharmaceutical company's products put patients at risk, they should be held accountable. For this reason, we will provide our qualified legal services on a contingency fee basis, so you will have no fees or costs unless we recover compensation for your claim.
Complete a Free Case Evaluation form to get started.
Free Case ReviewClick Here
$7,729,000 Verdict
$7,729,000Verdict
The plaintiff was a boilermaker at a Baltimore area shipyard from the late 1950s through the late 1970s. He was deceased by the time the trial started. His estate and his family received a verdict against a Joiner contractor whose sawing and installing of asbestos-containing bulkhead panels on board ships exposed our client to this deadly toxin. In addition to awarding money to the plaintiff's estate, the jury also awarded compensation to his widow and six children.
The plaintiff was a vending machine operator who provided coffee, snacks and refreshments to workers on board ships during ship construction in Baltimore. The plaintiff testified at trial and explained how he was exposed to asbestos dust from the work going on around him on board the ships. The plaintiff and his wife received the compensatory damages awarded by the jury.
Judgment of more than $7,000,000 was obtained on behalf of our client who suffered severe developmental disabilities as a result of a pediatrician's failure to diagnose a heart condition during infancy.*
The plaintiff was a security guard who was exposed to asbestos dust on board ships being constructed at a Baltimore shipyard. The plaintiff was deceased by the time trial began and a coworker explained how he would oversee workers and security on board the ships while they were being constructed. Our client's estate and his three daughters received compensatory damages from the jury.
Peter T. Nicholl and Bill tried this case to verdict.
"This office has been handling my case for asbestos damage for years. Very professional and responsible."
Contact our personal injury lawyers for a free consultation if you have been injured by another's negligence. You may be entitled to compensation.
GET WHAT YOU DESERVE
Local phone 410-244-7005
36 South Charles Street, Suite 1700
355 Crawford Street
Portsmouth, VA 23704
I need legal hel for
I need legal help for: Asbestos-Mesothelioma / Lung Cancer Auto & Construction Accidents Bad Faith Insurance Defective Products & Machinery Lead Paint Poisoning Medical Mistakes Nursing Home Neglect Prescription Drugs Injuries Social Security Disability Toxic Substance Exposure Wage & Hour / Unpaid Overtime Issues Whistleblower - Qui Tam Other
THE LAW OFFICES OF PETER T. NICHOLL | © 2020 Peter T. Nicholl | Privacy Policy | Sitemap | Legal/Terms


text:
Tags: Russian poets
Alexander Griboyedov
... - ...
Aleksandr Galich
Demyan Bedny
1 (13) April 1883 - 25 May 1945
Konstantin Balmont
15 June (O.S. 3 June) 1867 - December 23, 1942
Afanasy Fet
December 5, 1820 - December 3, 1892
October 15 [O.S. October 3] 1814 - July 27 [O.S. July 15] 1841
Valery Bryusov
December 13 [O.S. December 1] 1873 - October 9, 1924
Andrei Bely
October 26 [O.S. October 14] 1880 - January 8, 1934
Nikolai Gumilyov
April 15, 1886 - August 1921
July 19 [O.S. July 7] 1893 - April 14, 1930
July 21, 1882 - January 15, 1967
Aleksei (Alexander) Kruchenykh
February 21, 1886 - June17, 1968
Vasily Kamensky
April 17 [O.S. April 5] 1884 - November 11, 1961
Mikhail Kuzmin
October 18 [O.S. October 6] 1872 - March 1, 1936
Velimir Khlebnikov
November 9, 1885 (October 28, 1885 (O.S.)) - June 28, 1922
January 15 [O.S. January 3], 1891 - 1891 – December 27, 1938
June 23 [O.S. June 11], 1889 - March 5, 1966
Sasha Chorny
13 October 1880 N.S - 5 July 1932
24 May 1940 - 28 January 1996
Dmitrii Bykov
20 December 1967 - ...
Dmitri Prigov
Sergey Mikhalkov
February, 28th (on March, 13th) 1913 - 27 August 2009
18 July 1932 - ...
Bella Akhmadulina
April, 10th, 1937 - November, 29th, 2010
March, 31st, 1882 - October, 28th, 1969
February 17 (O.S. February 4) 1906 - April 1, 1981
Natalya Gorbanevskaya
26 May 1936 - ...
Vadim Delaunau
December, 22nd, 1947 in Moscow - June, 13th, 1983 in Paris
Aleksei Reshetov
April, 3rd, 1937 - September, 30th, 2002
Gavrila Derzhavin
Fyodor Sologub
March 1 [O.S. February 17] 1863 - December 5, 1927
Nikolay Rubtsov
3 January 1936 - 19 January 1971
Aleksey Koltsov
Rimma Kazakova
Anna Bunina
January 18, 1774 - December 16, 1829
Nikolai Klyuev
October 10, 1884 - between October 23 and 25, 1937
Sergei Klychkov
1 on July (13) 1889 - On October 8 1937
Apollon Maykov
June 4 [O.S. May 23] 1821 - March 20 [O.S. March 8] 1897
Elena Guro
Dmitry Merezhkovsky
August 2 (14), 1865 - December 9, 1941
Vladimir Solovyov
January 16, 1853 - July 31, 1900
Alexander Tvardovsky
June 8 (21), 1910 - December 18, 1971
Boris Kornilov
July 16, 1907 - February 21, 1938
Anna Akhmatova Museum Opened in Moscow
A museum on life and creativity of Anna Akhmatova has been founded at the antiquarian book house "In Nikitsky".
Symbolism in Russian Literature of the Silver Age
Symbolist poetry is meant for aristocrats of the spirit. The symbol is the tool helping to break on through the veil of daily routine to the higher reality. The poet's calling is to connect the realistic earthly world with ultramundane realms.
Alexander Pushkin is the Most Popular Poet in RuNet
Yandex.ru has analyzed users' interest in the Russian poetry and published the research results.
Moscow Museum of S. A. Esenin
If you are looking for some great insight into Moscow literary life, we recommend you to visit a museum of the famous Russian poet Sergey Esenin. This fascinating place is a hidden gem in the city centre that is not always included in guide books, but really deserves attention of tourists.
City Hunter: Marina Tsvetaeva's Memorial Flat
Today we invite you to travel to one of the most fascinating Moscow attractions – a house, where Marina Tsvetaeva, a famous Russian poet lived and where she created her magnificent poetry.
Beautiful Poems About Russian Winter
Russian winter is not just a very cold weather with frost and snow. It is a beautiful and even romantic time, which always was an inspiration for many Russian writers, poets, artists and musicians. Their works help people to understand not only charm of Russian winter, but to get to know peculiarity of mysterious Russian soul. Today we'll proudly show you some poems about Russian winter by the best Russian poets in English translation. Enjoy!
Golden Age of Russian Poetry
The sparkling term Golden Age is referred to the first half, or to be more exact, the first forty years of the 19th century. This period is remarkable for an unprecedented upsurge of creativity illuminated by the genius of Alexander Pushkin. It was the poetry of the early 19th century that turned to be the impetus, which still goes on driving Russian literature forth
Silver Age of Russian Poetry
With the end of the 19th century "the Golden Age" of Russian literature finished giving place to a crucial stage that later went down into history under the beautiful name of the Silver Age. It engendered a great flight of Russian culture, at the same time becoming a beginning of its tragic fall down.
Alexander Pushkin Festival Launched in New York
The art and music festival dedicated to the 220th anniversary since the birth of Alexander Pushkin has kicked off in New York.
Fomenko Studio to Celebrate 80th Anniversary of Bella Akhmadulina
Bella Akhmadulina, one of the brightest poet Sixtiers, would have turned 80 today, April 10, 2017.
Poet Yevgeny Yevtushenko Died in the USA
The famous Russian poet died at the age of 85 on April 1. At his last will, Yevgeny Yevtushenko will be buried in Peredelkino, Moscow.
Over 100 Events Timed to 125th Anniversary of Marina Tsvetaeva
More than 100 events will be held in Russia in honor of the 125th anniversary of the famous poet Marina Tsvetaeva.
Yevgeny Yevtushenko Debuted in Red Square
The renowned poet recited his writings to visitors of the Book Festival "Red Square" opened in Moscow today.
125th Anniversary of Poet Osip Mandelstam Celebrated in Moscow
As the Moscow Culture Department reports, hundreds of events dedicated to the anniversary since the poet's birth have been planned.
Vladimir Vysotsky's Death Mask Set for an Auction
French actress Marina Vlady, the widow of the famous Russian singer-songwriter Vladimir Vysotsky, has put up his personal art collection for auction.
Jubilee of Sergey Yesenin Celebrated with a Stage Production in Muzeon
Today the Muzeon arts park, Moscow, welcomes all for a free performance timed to the 120th anniversary since Sergey Yesenin's birthday.
Vladimir Vysotsky Commemorated in Moscow Hermitage Garden
Hundreds of people venerated memory of Vladimir Vysotsky in the garden Hermitage on July 25, the day of the actor's death.
Filming of Kharms Biopic Completed in St. Petersburg
Shooting of a feature film about the famous Russian writer and poet Daniil Kharms has been completed in St. Petersburg.
Joseph Brodsky Monument to be Set Up in Moscow
Monument to Joseph Brodsky will be set up on the firewall by the Muruzi House in 24, Liteyny Avenue.
Rarities of Anna Akhmatova's Collection Now in Literary Museum
I. S. Ostroukhov's House holds the exhibition Rarities of Anna Akhmatova's Collection in the State Literary Museum.
Yesenin Museum to be Restored in Moscow
Competition for restoration of the Sergey Yesenin Museum in Moscow has been started.
Joseph Brodsky Museum to Appear in St. Petersburg
The apartment museum of the Nobel Prize winner Joseph Brodsky will be opened in Liteyny Avenue in St. Petersburg in May 2015.
Lermontov Memorial House Museum Restored in Moscow
Mikhail Lermontov Memorial House Museum has been opened upon restoration in Moscow.
Exhibition for Mandelstam's Anniversary Held in Petersburg
The exhibition dedicated to Osip Mandelstam is timed to the 75th anniversary since the death of the poet.
Exhibition of Artist and Poet Vladimir Kovenatsky Starts in Moscow
Moscow State Museum of Folk Graphic Art opens the exhibition Chained to Art… in memory of the artist and poet Vladimir Kovenatsky (1938-1986).
Olga Berggolts Museum Opens in Saint Petersburg
Museum of poetess Olga Berggolts has been opened at School No. 340 of Nevsky District in Saint Petersburg.
Poetry Living Legend Yevgeny Yevtushenko Is 80 Today
Today a famous Soviet and Russian poet, "the last hero" of the "poets of the sixties" pleiad, Yevgeny Yevtushenko, marks his 80th birthday.
Exhibition of Anna Akhmatova's Portraits Opens in Petersburg
Exhibition "Anna Akhmatova. Mythology of Image" has opened in the poetess' museum in Fontanny House.
contemporary art Giving Hope Gelendzhik Russia-Britain Pussy Riot Lace tourist trains travel to Russia Mercedes-Benz Fashion Week Russia Moscow Proton Therapy New Museum Ludmila Senchina Motor race Russian writers Soviet Russian Cinema St. Petersburg Sun Meeting Platform Oleg Anofriyev migration in Russia Vologda region Exhibitions in Moscow Festivals in Moscow Russian Poets Computers Republic of Bashkortostan Dagestan ROSCOSMOS Bast Shoes Russian tourism Semyon Chelyuskin Space Simulator Russian politicians Russian Film Distribution Russian law enforcement Alyosha Dmitrievich Festivals in Saint Petersburg Fires Ecotourism Tver region Exhibitions in St. Petersburg Moscow Region banned books Russian business Russian regions Maria Komissarova Eurovision Russian football team Universitetskaya-1


Attention! You are viewing a resized version of this drawing. There is a larger version available, which is of better clarity. Click on the image below to view it.
ShockTillYouDrop.com announced a Halloween II Fan Movie Poster Contest towards the end of July. The idea behind this is that one can create a movie poster based on the upcoming Rob Zombie movie Halloween II, and send it to them. The contest ends on Aug 28 (the movie's release date in the US), and at that time Rob Zombie himself would pick out the winning entry, and the creator would receive a print of the poster signed by him.
I was not sure if the contest is open to people outside the US (the site didn't say anything about that), but I thought I'd do something anyway regardless of the result. Rather than Photoshopping together existing movie stills, I did a drawing and used that for my poster design. It is based on screenshots from the trailer and one official still. It features the characters Michael Myers (Tyler Mane), Laurie Strode (Scout Taylor-Compton) and Dr Sam Loomis (Malcolm McDowell). The drawing was done using a black ballpoint pen, a thick red marker, a thin black marker, and a thick black marker that was running out of ink (that helped me get the shading on Myers' jacket). It was done over the course of a couple of weekends (starting in the beginning of August, finishing on 9-Aug-09).
I scanned in the drawing at 600 dpi, and then used a Photoshop document size of 27 inches by 40 inches (the standard US "one-sheet" size) at 200 dpi to create the final poster. The background paper texture is a stock image by Lasse Korsgaard from this pack, and the Halloween II title logo was provided by STYD (though I had to upscale that considerably). The typeface used for the credit block is Franklin Gothic, which seemed to go well with the overall look.
I've uploaded a 1000 pixel-wide image here, though I have a 5400 pixel-wide image with me. I am planning to send the STYD guys a 2000 pixel-wide version after writing this. An interesting thing about this 1000 px version is that Windows reports the filesize as 666 KB.
I also recorded video footage while doing the drawing and putting together the poster. I've edited that into a video which I've uploaded on YouTube. You can watch it by clicking here or on the image above. I am pretty proud of the video too. I think I've gotten better at this overall — this video uses more varied shots to make it seem that I had different camera setups, whereas it was just me filming everything with mostly my Nokia N82 cellphone (a couple of shots were filmed with my laptop webcam). The video as usual is shot mostly handheld.
Ad - Words as this method involves monetary investment.
for the identical services or products you sell.
That person was using this medication on as well as on and also on.